Found 188 matching trials
A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM) NA The objectives of the study is to evaluate the efficacy, safety, and dose o...
Show More Location
Heishinkai Medical Group Incorporated OCROM Clinic
Learn More & Join Trial
Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation PHASE3 People living with human immunodeficiency virus infection (HIV) have 2-4fol...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
12-Week Study of DS-8500a in Subjects With Type 2 Diabetes Mellitus on Metformin PHASE2 The hypothesis of this Phase 2, 12-week study, is that DS-8500a will improv...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017) PHASE3 This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...
Show More Location
Multiple Locations
Learn More & Join Trial
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1) PHASE3 The purpose of the study is to compare how sitagliptin and glipizide lower ...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of DPP4 Inhibition on Vasoconstriction PHASE4 The purpose of this study is to understand how dipeptidyl peptidase IV (DPP...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
Sitagliptin in Renal Transplant Recipients PHASE4 The major cause of premature death in renal transplant recipients is cardio...
Show More Location
Rikshospitalet Medical Center
Learn More & Join Trial
Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes PHASE3 The purpose of this study is to evaluate the efficacy of 2 doses of TAK-875...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin PHASE1 This study will assess the safety, tolerability, pharmacokinetics (explores...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of Sitagliptin in Relatives of T1D Patients PHASE2 Type 1 Diabetes (T1D) is a chronic autoimmune disease, with a genetic backg...
Show More Learn More & Join Trial